Publication Cover
Chronobiology International
The Journal of Biological and Medical Rhythm Research
Volume 20, 2003 - Issue 3
224
Views
28
CrossRef citations to date
0
Altmetric
Original

Circadian Rhythms of Oxidative Phosphorylation: Effects of Rotenone and Melatonin on Isolated Rat Brain Mitochondria

, , , &
Pages 451-461 | Received 17 Dec 2002, Accepted 07 Feb 2003, Published online: 07 Jul 2009

References

  • Acuna-Castroviejo D., Martin M., Macias M., Escames G., Leon J., Khaldy H., Reiter R. Melatonin, mitochondria, and cellular bioenergetics. J. Pineal Res. 2001; 30: 65–74
  • Arnold S., Goglia F., Kadenbach B. 3,5-Diiodothyronine binds to subunit Va of cytochrole-c oxidase and abolished the allosteric inhibition of respiration by ATP. Eur. J. Biochem. 1998; 252: 325–330
  • Betarbet R., Sherer T., MacKenzie G., et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 2000; 3: 1301–1306
  • Betarbet R., Sherer T. B., Greenamyre J. T. Animal models of Parkinson's disease. Bioessays 2002; 24: 308–318
  • Blake C., Spitz E., Leehey M., Hoffer B., Boyson S. Platelet mitochondrial respiratory chain function in Parkinson's disease. Mov. Disord. 1997; 12: 3–8
  • Dabbeni-Sala F., Di Santo S., Franceschini D., Skaper S., Giusti P. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity. FASEB J. 2001; 15: 164–170
  • Greenamyre J., MacKenzie G., Peng T., Stephans S. Mitochondrial dysfunction in Parkinson's disease. Biochem. Soc. Symp. 1999; 66: 85–97
  • Heimer G., Bar-Gad I., Goldberg J. A., Bergman H. Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-terahydropyridine primate model of Parkinson. J. Neurosci. 2002; 22: 7850–7855
  • Jin B. K., Shin D. Y., Jeong M. Y., et al. Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats. Neurosci. Lett. 1998; 245: 61–64
  • Kirkey K., Johnson C., Rybicki B., Peterson E., Kortsha G., Gorell J. Occupational categories at risk for Parkinson's disease. Am. J. Ind. Med. 2001; 39: 564–571
  • Lowry O. H., Resebrough N. J., Farr A. J., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193: 265–275
  • Marder K., Logroscino G., Alfaro B., et al. Environmental risk factors for Parkinson's disease in an urban multiethnic community. Neurology 1998; 50: 279–281
  • Martin M., Macias M., Escames G., Reiter R., Agapito M. T., Ortiz G. G., Acuna-Castroviejo D. Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo. J. Pineal Res. 2000; 28: 242–248
  • Martin M., Macias M., Leon J., Escames G., Khaldy H., Acuna-Castroviejo D. Melatonin increased the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. Int. J. Biochem. Cell Biol. 2002; 34: 348–357
  • Mizuno Y., Ohta S., Tanaka M., Takamiya S., Suzuki K., Sato T., Oya H., Ozawa T., Kagawa Y. Deficiences in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 1989; 163: 1450–1455
  • Morin C., Zini R., Simon N., Charbonnier P., Tillement J. P., Le Louet H. Low glucocorticoid concentrations decrease oxidative phosphorylation of isolated rat brain mitochondria: an additional effect of dexamethasone. Fundam. Clin. Pharmacol. 2000; 14: 493–500
  • Morin C., Zini R., Simon N., Tillement J. P. Dehydroepiandosterone and alpha-estradiol limit the functional alterations of rat brain mitochondria submitted to different experimental stresses. Neuroscience 2002; 115: 415–424
  • Murphy M. P. How understanding the control of energy metabolism can help investigation of mitochondrial dysfunction, regulation and pharmacology. Biochim. Biophys. Acta 2001; 1504: 1–11
  • Pinna G., Brödel O., Visser T., Jeitner A., Grau H., Eravci M., Meinhold H., Baumgartner A. Concentrations of seven Iodothyronine metabolites in brain regions and the liver of the adult rat. Endocrinology 2002; 143: 1789–1800
  • Rossignol R., Malgat M., Mazat J. P., Letellier T. Threshold effect and tissue specificity. J. Biol. Chem. 1999; 274: 33426–33432
  • Rustin P., Chrétien D., Bourgeron T., et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta 1994; 228: 35–51
  • Simon N., Zini R., Morin C., Bree F., Tillement J. P. Prednisolone and azathioprine worsen the cyclosporine A-induced oxidative phosphorylation decrease of kidney mitochondria. Life Sci. 1997; 61: 659–666
  • Simon N., Morin C., Urien S., Tillement J. P., Bruguerolle B. Tacrolimus and Sirolimus decrease oxidative phosphorylation of isolated rat kidney mitochondria. Br. J. Pharmacol. 2003; 138: 369–376
  • Urien S. MicroPharm-K, a microcomputer interactive program for the analysis and simulation of pharmacokinetic processes. Pharm. Res. 1995; 12: 1225–1230
  • Willis G., Armstrong S. A therapeutic role for melatonin antagonism in experimental models of Parkinson's disease. Physiol. Behav. 1999; 66: 785–795

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.